Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Tackenberg

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Scientific Reports|June 14, 2017
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticusRana Raoof, Eva M Jimenez-Mateos, Sebastian Bauer, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple SclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
The Journal of Clinical Investigation|December 11, 2012
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitisMagdalena Huber, Sylvia Heink, Axel Pagenstecher, et al.
Neurology|October 27, 2012
Neurofascin as a target for autoantibodies in peripheral neuropathiesJudy King Man Ng, Joachim Malotka, Naoto Kawakami, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesIngemar S J Merkies, Ivo N van Schaik, Jean-Marc Léger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Cell Reports. Medicine|March 19, 2025
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosisIvan Jelcic, Reza Naghavian, Imran Fanaswala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
PML risk stratification using anti-JCV antibody index and L-selectinNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Scientific Reports|June 14, 2017
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticusRana Raoof, Eva M Jimenez-Mateos, Sebastian Bauer, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple SclerosisJessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, et al.
The Journal of Clinical Investigation|December 11, 2012
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitisMagdalena Huber, Sylvia Heink, Axel Pagenstecher, et al.
Neurology|October 27, 2012
Neurofascin as a target for autoantibodies in peripheral neuropathiesJudy King Man Ng, Joachim Malotka, Naoto Kawakami, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesIngemar S J Merkies, Ivo N van Schaik, Jean-Marc Léger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Cell Reports. Medicine|March 19, 2025
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosisIvan Jelcic, Reza Naghavian, Imran Fanaswala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
PML risk stratification using anti-JCV antibody index and L-selectinNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Pageof 9